產品編號 | bsk11024 |
英文名稱 | Human VEGF ELISA Kit |
中文名稱 | 人血管內皮生長因子酶聯免疫試劑盒 |
別 名 | Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; Vegf; VEGFA; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGF A Precursor. |
Specific References (3) | bsk11024 has been referenced in 3 publications.
[IF=12.658] Tu Zewei. et al. Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy. J EXP CLIN CANC RES. 2023 Dec;42(1):1-19 ELISA ; Human.
[IF=6.244] Yang Chenbo. et al. Relationship Between PTEN and Angiogenesis of Esophageal Squamous Cell Carcinoma and the Underlying Mechanism. Front Oncol. 2021 Nov;0:4638 ELISA ; Human.
[IF=5.275] Tian-Wen Ni. et al. Alkaloid derivative ION-31a inhibits breast cancer metastasis and angiogenesis by targeting HSP90α. Bioorg Chem. 2021 Oct;115:105201 ELISA ; Mouse.
|
|
種 屬 | Human |
線性范圍 | 31.25 - 2,000 pg/mL |
應用范圍 | S/P/CC |
檢測限 | 7 pg/mL |
適用樣品基質 | cell culture supernates, serum, and plasma. |
保存條件 | Store at 4°C for 12 months. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產品介紹 |
This gene product is a member of the PDGF/VEGF growth factor family. It is a mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis, endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Also, alternative translation initiation from non-AUG (CUG) and AUG start sites in some transcript variants, give rise to additional isoforms. [provided by RefSeq]. |
產品圖片 | |
1、抗體溶解方法 | |
2、抗體修復方式 | |
3、常用試劑的配制 | |
4、免疫組化操作步驟 | |
5、免疫組化問題解答 | |
6、Western Blotting 操作步驟 | |
7、Western Blotting 問題解答 | |
8、關于肽鏈的設計 | |
9、多肽的溶解與保存 | |
10、酶標抗體效價測定程序 | |